Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

See How to

Filter conferences

Next Generation Cancer Vaccine Development 2022

Next Generation Cancer Vaccine Development 2022


Date of beginning

Tuesday, 16 August 2022


3 days




United States


Olivia Bull


This email address is being protected from spambots. You need JavaScript enabled to view it.


The 2nd Annual Next Generation Cancer Vaccine Development Summit returns as the only industry-dedicated meeting bringing you the most up-to-date clinical and commercial developments utilizing next-generation vaccines for solid tumours and other cancers. Why have we failed in the past and how can we succeed in the future? By deciphering the challenges of antigen selection, point mutations, delivery, and resistance mechanisms, the 2nd Next Generation Cancer Vaccine Development Summit will focus on overcoming the translational and clinical challenges of therapeutic and prophylactic vaccines for oncology indications. Gain access to fresh studies and discussions covering ‘Personalized vs Off-the-Shelf’, shared neoantigens, immuno-stimulating adjuvants, understanding the tumour microenvironment, and insights into cancer vaccine candidates currently under clinical assessment. Tickets Prices:Conference + Focus Day - Industry Pricing - On the Door USD 4097.00Conference Only - Industry Pricing - On the Door USD 2999.00Conference + Focus Day - Academic & NPO Pricing - On the Door USD 3497.00Conference Only - Academic & NPO Pricing - On the Door USD 2599.00Conference + Focus Day - Vendor Pricing - On the Door USD 4897.00Conference Only - Vendor Pricing - On the Door USD 3599.00 Speakers: Muna Abdullahi, Research Analyst, Beacon Targeted Therapies, Stephen Albert Johnston, Founding CEO, Calviri, Inc, Kathryn Sykes, VP Research and Product Development, Calviri, Inc, Ronald Plasterk, CEO, Frame Therapeutics, Alfredo Perales, Puchalt, VP, R&D, Geneos Theraputics, Joann Peters, VP, Clinical & Business Operations, Geneos Thraputics, Christine Palmer, Director, Clinical Immunology, Gritstone Bio, Ankur Dhanik, VP, Bioinformatics & Data Science, Gritstone Bio, Vipul Bhargava, Senior Principal Scientist, Janssen R&D, Robert Meehan, Senior Director, Clinical Development, Moderna, Agnete Fredriksen, Chief Innovation & Strategy Officer, Nykode, Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, Russell Pachynski, Associate Professor, Washington University School of Medicine, Tim Boyd, Director of Development, Partner Tx, Wouter Scheper, Senior Postdoctoral Fellow, Netherlands Cancer Institute, Brian Czerniecki, Chair, Department of Breast Oncology, Moffit Cancer Center, Ramireddy Bommireddy, Instructor, Department of Pathology and Laboratory Medicine, Winship Cancer Institute of Emory University, Nora Disis, Professor, Clinical Research Division, Fred Hutch, Anna Morena, D’Alise Head of Oncology, Nouscom, Jeffrey Bockman, Executive Vice President of Commercial BioConsulting & Head of Oncology, Lumanity, Jonathan Lovell, Associate Professor, Biomedical Engineering, University at Buffalo, Lelia Delamarre, Senior Principal Scientist, Genetech Dates and Time: Starts: Tue, Aug 16, 2022 ( 9:00 AM) and Ends: Thu, Aug 18, 2022 ( 4:00 PM) Venue details: Crowne Plaza Boston - Woburn, an IHG Hotel, 15 Middlesex Canal Park Rd, Woburn, Massachusetts, 01801, United States